Revenue Performance - The group's revenue decreased from approximately HKD 66,246,000 for the year ending December 31, 2024, to approximately HKD 44,495,000 for the year ending December 31, 2025, a reduction of about HKD 21,751,000[5]. - Revenue from the photography services segment decreased by approximately 51.2% to about HKD 21,190,000 for the year ending December 31, 2025, compared to HKD 43,415,000 for the year ending December 31, 2024[5]. - Medical services revenue increased by approximately 2.1% to about HKD 23,305,000 for the year ending December 31, 2025, compared to HKD 22,831,000 for the year ending December 31, 2024[5]. - The group's total revenue for the year ending December 31, 2025, was HKD 66,246,000, compared to HKD 44,495,000 for the year ending December 31, 2024, representing an increase of 48.9%[7]. - The group’s external customer revenue from Hong Kong was HKD 44,486,000 in 2025, down from HKD 65,329,000 in 2024, a decline of about 31.9%[19]. Profitability and Loss - The group's gross profit for the year ending December 31, 2025, was approximately HKD 12,069,000, with a gross profit margin of about 27.1%, down from HKD 20,277,000 and a margin of 30.6% for the previous year[6]. - The loss attributable to the company increased from approximately HKD 399,000 for the year ending December 31, 2024, to approximately HKD 4,598,000 for the year ending December 31, 2025, an increase of about HKD 4,199,000[6]. - The net loss attributable to shareholders was HKD 470,000, compared to a net loss of HKD 3,963,000 in the previous year, showing a reduction in losses by 88.1%[7]. - The group reported a net loss of HKD (4,200,000) before tax for the year ending December 31, 2025, compared to a profit of HKD 732,000 in 2024[17]. - The company reported a loss of approximately HKD 4,598,000 for the year, compared to a loss of HKD 399,000 in the previous year, with a weighted average of 800,000,000 ordinary shares issued[31]. Expenses and Cost Management - The company reported other income of HKD 301,000, down from HKD 639,000 in the previous year, reflecting a decrease of 52.9%[7]. - Administrative expenses increased to HKD 19,219,000 from HKD 15,691,000, marking a rise of 22.4%[7]. - The total service costs, including employee costs, depreciation, and lease expenses, amounted to approximately HKD 17,404,000, a decrease from HKD 30,410,000 in the previous year[29]. - The company incurred depreciation expenses of HKD 10,300,000 for the year, compared to HKD 9,938,000 in the previous year[29]. - Employee benefits expenses decreased from HKD 17,180,000 in 2024 to HKD 13,176,000 in 2025, reflecting a reduction in salary, bonuses, and allowances[26]. Assets and Liabilities - Total non-current assets decreased from HKD 19,032,000 to HKD 17,415,000, a decline of approximately 8.5% year-over-year[8]. - Current assets decreased from HKD 26,778,000 to HKD 18,483,000, representing a decrease of about 30.9% year-over-year[8]. - Total current liabilities increased from HKD 13,149,000 to HKD 13,462,000, an increase of approximately 2.4% year-over-year[8]. - Total assets decreased from HKD 32,661,000 to HKD 22,436,000, a decline of about 31.2% year-over-year[8]. - Total equity attributable to owners decreased from HKD 24,035,000 to HKD 14,699,000, a decrease of approximately 38.5% year-over-year[8]. Business Operations and Strategy - The company operates primarily in providing photography services through self-service identity photo booths and medical services in Hong Kong[10]. - The decline in photography services revenue was attributed to the expiration of a significant service contract and increased competition from traditional photography service providers[5]. - The company is reallocating resources to enhance the self-service identity photo machine business, focusing on upgrading equipment and promotional activities[41]. - The medical services business in Hong Kong showed stable financial growth, despite lower revenue from flu vaccination due to a shortened flu season[43]. - The company is exploring the feasibility of establishing new medical centers and partnerships to expand its medical services business, although no new centers were established in the past year[43]. Future Outlook - The company plans to focus on market expansion and new product development in the upcoming fiscal year[7]. - Future guidance indicates a positive outlook with expectations of continued revenue growth and improved profitability metrics[7]. - The Hong Kong government's healthcare reform, effective January 1, 2026, is expected to drive revenue growth for private medical institutions as consumers may shift towards private healthcare services[44]. - The focus on diversifying business operations and expanding revenue sources is crucial for sustainable growth and shareholder value creation[46]. Corporate Governance and Compliance - The company has adhered to all applicable corporate governance code provisions as of December 31, 2025[79]. - The company has adopted the trading standards as per GEM Listing Rules from December 31, 2025, confirming compliance by all directors[80]. - No purchase, sale, or redemption of the company's listed securities occurred by the company or its subsidiaries for the year ending December 31, 2025[81]. - The board consists of eight directors, including three independent non-executive directors, ensuring the protection of shareholder interests[83].
名仕快相(08483) - 2025 - 年度业绩